UNITED STATES ANTIMONY CORP
For the period ended Sep 30, 2024. Filed Nov 12, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 12, 2024
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
ITEM 1. FINANCIAL STATEMENTS
CONDENSED CONSOLIDATED BALANCE SHEETS (UNAUDITED)
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| ASSETS | ||
| CURRENT ASSETS | ||
| Cash and cash equivalents | $12,969,132 | $11,899,574 |
| Certificates of deposit | 22,257 | 72,898 |
| Accounts receivable, net | 791,557 | 625,256 |
| Inventories, net | 966,814 | 1,019,154 |
| Prepaid expenses and other current assets | 177,283 | 92,369 |
| Current assets held for sale (Note 12) | 74,560 | 366,955 |
| Total current assets | 15,001,603 | 14,076,206 |
| Properties, plants and equipment, net | 7,751,348 | 7,765,045 |
| Operating lease right-of-use asset | 764,035 | - |
| Restricted cash for reclamation bonds | 98,234 | 55,061 |
| Other assets | 20,217 | 18,098 |
| Noncurrent assets held for sale (Note 12) | 6,117,610 | 6,180,585 |
| Total assets | $29,753,047 | $28,094,995 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| CURRENT LIABILITIES | ||
| Accounts payable | $1,212,397 | $330,147 |
| Accrued liabilities | 164,917 | 109,341 |
| Accrued liabilities - directors | 159,165 | 124,810 |
| Royalties payable | 105,174 | 153,429 |
| Current portion of operating lease liability | 483,211 | - |
| Long-term debt, current portion | 131,105 | 28,443 |
| Current liabilities held for sale (Note 12) | 148,833 | 151,288 |
| Total current liabilities | 2,404,802 | 897,458 |
| Noncurrent liabilities: | ||
| Noncurrent operating lease liability | 299,435 | - |
| Long-term debt, net of current portion | 228,921 | - |
| Stock payable to directors | - | 38,542 |
| Asset retirement obligations | 1,156,374 | 1,101,561 |
| Noncurrent liabilities held for sale (Note 12) | 536,466 | 536,466 |
| Total liabilities | 4,625,998 | 2,574,027 |
| COMMITMENTS AND CONTINGENCIES (Note 9 and 12) | ||
| STOCKHOLDERS' EQUITY | ||
| Preferred stock $0.01 par value, 10,000,000 shares authorized: | ||
| Series A: 0 shares issued and outstanding | - | - |
| Series B: 750,000 shares issued and outstanding (liquidation preference $973,125 and $967,500, respectively) | 7,500 | 7,500 |
| Series C: 177,904 shares issued and outstanding (liquidation preference $97,847 both years) | 1,779 | 1,779 |
| Series D: 0 shares issued and outstanding | - | - |
| Common stock, $0.01 par value, 150,000,000 shares authorized; 108,438,984 and 107,647,317 shares issued and outstanding, respectively | 1,084,389 | 1,076,472 |
| Additional paid-in capital | 64,299,485 | 63,853,836 |
| Accumulated deficit | (40,266,104) | (39,418,619) |
| Total stockholders' equity | 25,127,049 | 25,520,968 |
| Total liabilities and stockholders' equity | $29,753,047 | $28,094,995 |
UNITED STATES ANTIMONY CORPORATION AND SUBSDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)
| For the three months ended | For the nine months ended | |||
|---|---|---|---|---|
| September 30, 2024 | September 30, 2023 | September 30, 2024 | September 30, 2023 | |
| REVENUES | $2,421,020 | $2,063,558 | $8,066,190 | $6,539,519 |
| COST OF REVENUES | 1,995,252 | 1,805,150 | 5,908,877 | 5,499,709 |
| GROSS PROFIT | 425,768 | 258,408 | 2,157,313 | 1,039,810 |
| OPERATING EXPENSES: | ||||
| General and administrative | 588,816 | 290,045 | 1,521,576 | 678,735 |
| Salaries and benefits | 429,438 | 228,967 | 956,402 | 502,071 |
| Professional fees | 165,839 | 103,127 | 564,525 | 340,194 |
| (Gain) loss on sale or disposal of property, plant and equipment, net | (16,252) | - | 1,242 | - |
| Other operating expenses | 102,970 | - | 240,961 | - |
| TOTAL OPERATING EXPENSES | 1,270,811 | 622,139 | 3,284,706 | 1,521,000 |
| LOSS FROM OPERATIONS | (845,043) | (363,731) | (1,127,393) | (481,190) |
| OTHER INCOME (EXPENSE): | ||||
| Interest and investment income | 157,757 | 176,656 | 460,529 | 466,809 |
| Trademark and licensing income | 6,553 | 6,117 | 21,281 | 25,023 |
| Other miscellaneous income (expense) | (2,364) | (3,827) | (7,117) | 74,922 |
| TOTAL OTHER INCOME | 161,946 | 178,946 | 474,693 | 566,754 |
| INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES | (683,097) | (184,785) | (652,700) | 85,564 |
| Income tax expense | - | - | - | - |
| INCOME (LOSS) FROM CONTINUING OPERATIONS | (683,097) | (184,785) | (652,700) | 85,564 |
| Discontinued operations: | ||||
| Loss from discontinued operations before income taxes | (44,412) | (1,459,743) | (194,785) | (2,873,541) |
| Income tax expense | - | - | - | - |
| Loss from discontinued operations (Note 12) | (44,412) | (1,459,743) | (194,785) | (2,873,541) |
| Net loss | (727,509) | (1,644,528) | (847,485) | (2,787,977) |
| Preferred dividends | (1,875) | (1,875) | (5,625) | (5,625) |
| Net loss available to common stockholders | $(729,384) | $(1,646,403) | $(853,110) | $(2,793,602) |
| Basic and diluted earnings per common share: | ||||
| Income (loss) from continuing operations | $(0.01) | $nil | $(0.01) | $nil |
| Income (loss) from discontinued operations | $nil | $(0.01) | $nil | ($0.03) |
| Net income (loss) | $(0.01) | $(0.01) | $(0.01) | ($0.03) |
| Weighted average shares outstanding: | ||||
| Basic | 108,438,984 | 107,647,317 | 108,262,091 | 107,519,786 |
| Diluted | 108,438,984 | 107,647,317 | 108,430,139 | 107,519,786 |
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY (UNAUDITED)
For the three and nine months ended September****30, 2024 and 2023
| Total Preferred Stock · Common stock · Additional Paid In · Shares to be returned · Accumulated | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Shares · Amount · Shares · Amount · Capital · to treasury · Deficit · Total | |||||||||||||
| Balances, December 31, 2022 | 2,620,576 | $26,205 | 106,373,341 | $1,063,732 | $64,052,630 | ($202,980) | ($33,070,332) | $31,869,255 | |||||
| Conversion of Preferred Series D to common stock | (1,692,672) | (16,926) | 1,692,672 | 16,927 | (1) | - | - | - | |||||
| Common stock buyback and retirement | - | - | (418,696) | (4,187) | (198,793) | 202,980 | - | - | |||||
| Net loss | - | - | - | - | - | - | (806,984) | (806,984) | |||||
| Balances, March 31, 2023 | 927,904 | $9,279 | 107,647,317 | $1,076,472 | $63,853,836 | $ | - | ($33,877,316) | $31,062,271 | ||||
| Net loss | - | - | - | - | - | - | (336,465) | (336,465) | |||||
| Balances, June 30, 2023 | 927,904 | $9,279 | 107,647,317 | $1,076,472 | $63,853,836 | $ | - | ($34,213,781) | $30,725,806 | ||||
| Net loss | - | - | - | - | - | - | (1,644,528) | (1,644,528) | |||||
| Balances, September 30, 2023 | 927,904 | $9,279 | 107,647,317 | $1,076,472 | $63,853,836 | $ | - | (35,858,309) | $29,081,278 | ||||
| Balances, December 31, 2023 | 927,904 | $9,279 | 107,647,317 | $1,076,472 | $63,853,836 | $ | - | ($39,418,619) | $25,520,968 | ||||
| Share-based compensation | - | - | 791,667 | 7,917 | 198,008 | - | - | 205,925 | |||||
| Net loss | - | - | - | - | - | - | (322,768) | (322,768) | |||||
| Balances, March 31, 2024 | 927,904 | $9,279 | 108,438,984 | $1,084,389 | $64,051,844 | $ | - | ($39,741,387) | $25,404,125 | ||||
| Share-based compensation | - | - | - | - | 94,922 | - | - | 94,922 | |||||
| Net loss | - | - | - | - | - | - | 202,792 | 202,792 | |||||
| Balances, June 30, 2024 | 927,904 | $9,279 | 108,438,984 | $1,084,389 | $64,146,766 | $ | - | ($39,538,595) | $25,701,839 | ||||
| Share-based compensation | 152,719 | 152,719 | |||||||||||
| Net loss | (727,509) | (727,509) | |||||||||||
| Balances, September 30, 2024 | 927,904 | $9,279 | 108,438,984 | $1,084,389 | $64,299,485 | $ | - | ($40,266,104) | $25,127,049 | ||||
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)
| For the nine months ended | ||||
|---|---|---|---|---|
| September 30, 2024 · September 30, 2023 | ||||
| CASH FLOWS FROM OPERATING ACTIVITIES OF CONTINUING OPERATIONS: | ||||
| Net income (loss) from continuing operations | ($652,700) | $85,564 | ||
| Adjustments to reconcile net income (loss) from continuing operations to | ||||
| net cash provided (used) by operating activities of continuing operations: | ||||
| Depreciation and amortization | 340,217 | 247,882 | ||
| Accretion of asset retirement obligation | 54,813 | 1,125 | ||
| Noncash operating lease expense | 23,442 | - | ||
| (Gain) loss on sale or disposal of property, plant and equipment, net | 1,242 | - | ||
| Write-down of inventory to net realizable value | 63,574 | - | ||
| Share-based compensation | 453,566 | - | ||
| Allowance for doubtful accounts on accounts receivable | (30,746) | 43,560 | ||
| Other noncash items | (16,107) | (11,573) | ||
| Changes in operating assets and liabilities: | ||||
| Accounts receivable | (135,555) | (649,540) | ||
| Inventories, net | (11,234) | (77,749) | ||
| Prepaid expenses and other current assets | (84,914) | (99,367) | ||
| Other assets | (2,119) | - | ||
| Accounts payable | 882,250 | (63,005) | ||
| Accrued liabilities | 55,576 | (51,773) | ||
| Accrued liabilities – directors | 34,355 | 206,282 | ||
| Stock payable to directors | (38,542) | - | ||
| Change in operating lease liability | (4,831) | - | ||
| Royalties payable | (48,255) | (327,138) | ||
| Net cash provided (used) by operating activities of continuing operations | 884,032 | (695,732) | ||
| CASH FLOWS FROM INVESTING ACTIVITIES OF CONTINUING OPERATIONS: | ||||
| Proceeds from redemption of certificates of deposit | 50,641 | - | ||
| Proceeds from sale of properties, plants and equipment | 314,125 | - | ||
| Purchases of properties, plant, and equipment | (223,058) | (1,337,398) | ||
| Net cash provided (used) by investing activities of continuing operations | 141,708 | (1,337,398) | ||
| CASH FLOWS FROM FINANCING ACTIVITIES OF CONTINUING OPERATIONS: | ||||
| Payments on dividends payable | - | (787,730) | ||
| Principal payments on long-term debt | (71,139) | (70,049) | ||
| Net cash used by financing activities of continuing operations | (71,139) | (857,779) | ||
| Net cash flows provided (used) by continuing operations | 954,601 | (2,890,909) | ||
| CASH FLOWS FROM DISCONTINUED OPERATIONS: | ||||
| Net cash provided (used) by operating activities | 158,130 | (3,122,155) | ||
| Net cash used by investing activities | - | (182,322) | ||
| Net cash flows provided (used) by discontinued operations | 158,130 | (3,304,477) | ||
| NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH | 1,112,731 | (6,195,386) | ||
| CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT BEGINNING OF PERIOD | 11,954,635 | 19,117,666 | ||
| CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AT END OF PERIOD | $13,067,366 | $12,922,280 | ||
| NON-CASH FINANCING AND INVESTING ACTIVITIES: | ||||
| Common stock buyback and retirement | $ | - | $202,980 | |
| Conversion of Preferred Series D to Common Stock | - | $16,927 | ||
| Equipment purchased with note payable | $402,722 | $ | - | |
| Noncash recognition of new leases | $787,477 | $ | - | |
NOTE 1 - NATURE OF OPERATIONS
United States Antimony Corporation and its subsidiaries in the U.S. and Mexico (“USAC”, the “Company”, “Our”, “Us”, or “We”) sell processed antimony, zeolite, and precious metals products primarily in the U.S. and Canada. The Company processes antimony ore primarily into antimony oxide, antimony metal, and antimony trisulfide. Our antimony oxide is used to form a flame-retardant system for plastics, rubber, fiberglass, textile goods, paints, coatings, and paper, as a color fastener in paint, and as a phosphorescent agent in fluorescent light bulbs. Our antimony metal is used in bearings, storage batteries, and ordnance. Our antimony trisulfide is used as a primer in ammunition. In its operations in Idaho, the Company mines and processes zeolite, a group of industrial minerals used in soil amendment and fertilizer, water filtration, sewage treatment, nuclear waste and other environmental cleanup, odor control, gas separation, animal nutrition, and other miscellaneous applications. We recover certain amounts of precious metals, primarily gold and silver, at our plant in Montana from antimony concentrates.
Recent Development
The Company has two subsidiaries in Mexico, US Antimony de Mexico, S.A. de C.V. (“USAMSA”) and Antimonio de Mexico, S.A. de C.V. (“ADM”). The USAMSA subsidiary primarily includes the Company’s Madero antimony and precious metals plant in Parras de la Fuente Coahuila, Mexico and its Puerto Blanco antimony and precious metals plant in San Luis de la Paz Guanajuato, Mexico. On March 11, 2024, the Company shut down the operations of USAMSA and announced its intent to sell its USAMSA subsidiary. Since this announcement, the Company initiated an active search for buyers of USAMSA’s operations and/or assets. The accounting requirements for reporting USAMSA as a discontinued operation were met in the first quarter of 2024. SeeNote 12for further information. The Company will maintain its existing Los Juarez mining claims and concessions in Mexico, which are included in our ADM subsidiary. However, currently, the Company has no active operations in Los Juarez.
NOTE 2 - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES
In the opinion of management, the accompanying unaudited condensed consolidated financial statements contain all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of its financial position as of September 30, 2024, and its results of operations and cash flows for the three and nine months ended September 30, 2024 and 2023. The Condensed Consolidated Balance Sheet as of December 31, 2023, was derived from audited annual financial statements but does not contain all of the footnote disclosures from the annual financial statements.
These unaudited interim financial statements have been prepared by management in accordance with generally accepted accounting principles used in the United States of America (“U.S. GAAP”). These unaudited interim financial statements should be read in conjunction with the annual audited financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2023, filed with the Securities and Exchange Commission on April 12, 2024.
This summary of significant accounting policies of the Company is presented to assist in understanding the Company’s financial statements. These accounting policies conform to U.S. GAAP and have been consistently applied in the preparation of the financial statements.
The preparation of financial statements in accordance with accounting principles generally accepted in the United States of America requires the use of estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities known to exist as of the date the financial statements are published, and the reported amounts of revenues and expenses during the reporting period. Uncertainties with respect to such estimates and assumptions are inherent in the preparation of the Company's consolidated financial statements; accordingly, it is possible that the actual results could differ from these estimates and assumptions, which could have a material effect on the reported amounts of the Company's consolidated financial position and results of operations. Operating results for the three and nine-month periods ended September 30, 2024, are not necessarily indicative of the results that may be expected for the full year ending December 31, 2024.
Reclassifications
Certain reclassifications have been made to conform prior period amounts to the current presentation. These reclassifications have no effect on the results of operations, stockholders’ equity and cash flows as previously reported.
Assets Held for Sale and Discontinued Operations
The Company classifies assets and liabilities to be sold ("Disposal Group") as held for sale in the period when all of the applicable criteria are met, including: (i) management commits to a plan to sell, (ii) the Disposal Group is available to sell in its present condition, (iii) there is an active program to locate a buyer, (iv) the Disposal Group is being actively marketed at a reasonable price in relation to its fair value, (v) significant changes to the plan to sell are unlikely, and (vi) the sale of the Disposal Group is generally probable of being completed within one year. Management performs an assessment at least quarterly or when events or changes in business circumstances indicate that a change in classification may* *be necessary.
Assets and liabilities held for sale are presented separately within the Condensed Consolidated Balance Sheets with any adjustments necessary to measure the Disposal Group at the lower of its carrying value or fair value less costs to sell. Depreciation of property and equipment are not recorded while these assets are classified as held for sale. For each period the Disposal Group remains classified as held for sale, its recoverability is reassessed and any necessary adjustments are made to its carrying value.
The Company categorizes the assets and liabilities of a Disposal Group, or business component, as discontinued operations once management commits to a plan to sell, the business segment is available for immediate sale, management has initiated a plan to sell at a price that is reasonable in relation to its fair value, management anticipates the sale will occur within one year, and it is unlikely that significant changes will be made to the plan to sell. In addition, the business component must be comprised of operations and cash flows that are clearly distinguished from the rest of the entity. The results of discontinued operations are aggregated and presented separately in the Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Operations, and Condensed Consolidated Statements of Cash Flows.
Share-Based Compensation
The Company’s share-based awards consist of restricted stock units (“RSUs”) and stock options granted to employees, consultants, and directors of the Company.
RSUs are stock awards entitling the award recipient to a specified number of shares of the Company’s common stock as the award vests. Each RSU granted includes a service-based vesting condition. The Company calculates the fair value of RSUs on the grant date using the closing market price of the Company’s common stock on the grant date. The Company recognizes the grant date fair value of RSUs as share-based compensation expense ratably over the requisite service period, other than RSUs or portions of RSUs that vest on the grant date, in which case the grant date fair value of that RSU or portion of RSU is recognized as share-based compensation expense on the grant date. The Company recognizes forfeitures as they occur.
Stock options grant award recipients the option to purchase a specified number of shares of the Company’s common stock at an exercise price per share specified in the grant agreement as the stock options vest. Stock option grants include either a service-based vesting condition or performance-based vesting conditions with a specified contractual term. The Company calculates the fair value of stock options on the grant date using the Black-Scholes option-pricing model, which requires the Company to make estimates and assumptions, such as expected volatility, expected term, and risk-free interest rate. Service and performance conditions are not considered in determining the award’s fair value on the grant date. The Company recognizes share-based compensation expense related to stock option awards from the grant date through the vesting date. For service-based vesting stock option grants, the Company expenses the grant date fair value of the award ratably over the requisite service period. For performance-based vesting stock option grants, the Company expenses the grant date fair value of the award ratably from the grant date through the vesting date based on the probability and timing of achieving the performance conditions. The Company recognizes forfeitures as they occur.
The expense related to employee and consultant share-based awards is recorded in “Salaries and benefits” and the expense related to director share-based awards is recorded in “General and administrative” in the Condensed Consolidated Statements of Operations.
Leases
The Company determines if an arrangement contains a lease at inception. An arrangement contains a lease if it implicitly or explicitly identifies an asset to be used and conveys the right to control the use of the identified asset in exchange for consideration. As a lessee, the Company includes operating leases in "Operating lease right-of-use assets" and "Current and noncurrent operating lease liabilities" in its Condensed Consolidated Balance sheet. Right-of-use assets represent the Company's right to use an underlying asset for the lease term and lease liabilities represent the Company's obligation to make lease payments arising from the lease. Operating lease right-of-use assets and liabilities are recognized upon commencement of the lease based on the present value of the lease payments over the lease term. Incremental costs of a lease that would not have been incurred if the lease had not been obtained are capitalized as initial direct costs (“IDC”). The Company amortizes the undiscounted fixed lease cost and the IDC on a straight-line basis over the lease term. If a lease does not provide an implicit interest rate, the Company uses its incremental borrowing rate based on the information available at commencement date to determine the present value of lease payments.
Recent Accounting Pronouncements
Management does not believe that any recently issued, but not yet effective, accounting pronouncements, if currently adopted, would have a material effect on the Company’s financial statements.
In November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures, amending reportable segment disclosure requirements to include disclosure of incremental segment information on an annual and interim basis. Among the disclosure enhancements are new disclosures regarding significant segment expenses that are regularly provided to the chief operating decision-maker and included within each reported measure of segment profit or loss, as well as other segment items bridging segment revenue to each reported measure of segment profit or loss. The amendments in ASU 2023-07 are effective for fiscal years beginning after December 15, 2023, and for interim periods beginning January 1, 2025, and are applied retrospectively. Early adoption is permitted. We are currently evaluating the effect the updated standard will have on our consolidated financial statements and disclosures.
In December 2023, the FASB issued ASU 2023-09, Income Taxes (Topic 740): Improvement to Income Tax Disclosures, amending income tax disclosure requirements for the effective tax rate reconciliation and income taxes paid. The amendments in ASU 2023-09 are effective for fiscal years beginning after December 15, 2024 and are applied prospectively. Early adoption and retrospective application of the amendments are permitted. We are currently evaluating the effect the updated standard will have on our consolidated financial statements and disclosures.
NOTE 3 – EARNINGS PER SHARE
Basic Earnings Per Share (“EPS”) is computed as net income (loss) available to common stockholders divided by the weighted average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution that could occur from common shares issuable through stock options, RSUs, warrants, and convertible preferred stock.
At September 30, 2024 and 2023, the potentially dilutive common stock equivalents not included in the calculation of diluted earnings per share as their effect would have been anti-dilutive were as follows:
| September 30, 2024 | September 30, 2023 | |
|---|---|---|
| Warrants | 12,346,215 | 12,346,215 |
| Stock options and RSU awards | 6,408,333 | - |
| Total possible dilution | 18,754,548 | 12,346,215 |
NOTE 4 – REVENUE RECOGNITION
Products consist of the following:
| · | Antimony: includes antimony oxide, antimony metal, antimony trisulfide. |
| · | Zeolite: includes coarse and fine zeolite crushed in various sizes. |
| · | Precious metals: includes unrefined and refined gold and silver. |
Sales of products for the three months ended September 30, 2024 and 2023 were as follows:
| For the three months ended | ||
|---|---|---|
| September 30, 2024 | September 30, 2023 | |
| Antimony product revenue | $1,338,640 | $1,391,733 |
| Zeolite product revenue | 682,947 | 671,825 |
| Precious metals product revenue | 399,433 | - |
| TOTAL REVENUES | $2,421,020 | $2,063,558 |
Sales of products for the nine months ended September 30, 2024 and 2023 were as follows:
| For the nine months ended | ||
|---|---|---|
| September 30, 2024 | September 30, 2023 | |
| Antimony product revenue | $5,381,803 | $4,356,077 |
| Zeolite product revenue | 2,280,338 | 1,941,009 |
| Precious metals product revenue | 404,049 | 242,433 |
| TOTAL REVENUES | $8,066,190 | $6,539,519 |
Domestic and foreign revenues for the three months ended September 30, 2024 and 2023 were as follows:
| For the three months ended | ||
|---|---|---|
| September 30, 2024 | September 30, 2023 | |
| Domestic revenues | $1,897,120 | $1,541,870 |
| Foreign revenues | 523,900 | 521,688 |
| TOTAL REVENUES | $2,421,020 | $2,063,558 |
Domestic and foreign revenues for the nine months ended September 30, 2024 and 2023 were as follows:
| For the nine months ended | ||
|---|---|---|
| September 30, 2024 | September 30, 2023 | |
| Domestic revenues | $6,346,717 | $5,126,304 |
| Foreign revenues | 1,719,473 | 1,413,215 |
| TOTAL REVENUES | $8,066,190 | $6,539,519 |
The Company’s trade accounts receivable balance related to contracts with customers was $791,557 at September 30, 2024 and $625,256 at December 31, 2023, net of an allowance for doubtful accounts related to trade accounts receivables of $240,466 and $271,212 at September 30, 2024 and December 31, 2023, respectively. The Company’s products do not involve any warranty agreements and product returns are not typical.
NOTE 5– INVENTORIES
Inventories at September 30, 2024 and December 31, 2023 consisted primarily of finished antimony metal and antimony oxide products, antimony ore and concentrates, and finished zeolite products. Inventories are stated at the lower of first-in, first-out cost or estimated net realizable value. Finished antimony products and finished zeolite products costs primarily include direct materials, direct labor, overhead, depreciation, and freight. Inventories at September 30, 2024 and December 31, 2023 were as follows:
| September 30, 2024 | December 31, 2023 | |
|---|---|---|
| Antimony oxide inventory | $230,958 | $252,927 |
| Antimony metal inventory | 145,129 | 237,429 |
| Antimony ore and concentrates inventory | 35,670 | 23,752 |
| Total antimony inventory | 411,757 | 514,108 |
| Zeolite inventory | 555,057 | 505,046 |
| TOTAL INVENTORIES | $966,814 | $1,019,154 |
At September 30, 2024 and December 31, 2023, inventories were valued at cost, except for the portion of inventory related to zeolite at September 30, 2024, which was valued at net realizable value because costs were greater than the amount the Company expected to receive on the sale of zeolite inventory. The adjustment to value inventory at net realizable value was $63,574 and $nil at September 30, 2024 and 2023, respectively.
Antimony oxide and metal inventory consisted of finished products held by the Company’s plant in Montana. Antimony ore and concentrates were held primarily at its plants in Montana and Mexico. The Company’s zeolite inventory consisted primarily of saleable zeolite material at the Company’s plant located in Idaho.
NOTE 6 – PROPERTIES, PLANTS AND EQUIPMENT
The major components of the Company’s properties, plants and equipment (“PP&E”) by segment at September 30, 2024 and December 31, 2023 were as follows:
| September 30, 2024 · Antimony Segment · Zeolite Segment · Precious Metals | |||||
|---|---|---|---|---|---|
| USAC | Mexico | BRZ | Segment | TOTAL | |
| Plant and equipment | $1,971,255 | $394,545 | $6,576,506 | $234,174 | $9,176,480 |
| Buildings | 243,248 | 11,970 | 1,705,893 | - | 1,961,111 |
| Mineral rights and interests | 10,000 | 100,000 | 16,753 | - | 126,753 |
| Land | 1,493,609 | 914,443 | - | - | 2,408,052 |
| Construction in progress | - | - | 45,253 | - | 45,253 |
| PP&E, cost | $3,718,112 | $1,420,958 | $8,344,405 | $234,174 | $13,717,649 |
| Accumulated depreciation | (1,765,977) | (247,094) | (3,762,123) | (191,107) | (5,966,301) |
| PP&E, net | $1,952,135 | $1,173,864 | $4,582,282 | $43,067 | $7,751,348 |
| December 31, 2023 · Antimony Segment · Zeolite Segment · Precious Metals | |||||
|---|---|---|---|---|---|
| USAC | Mexico | BRZ | Segment | TOTAL | |
| Plant and equipment | $1,971,255 | $394,545 | $6,007,694 | $234,174 | $8,607,668 |
| Buildings | 243,248 | 11,970 | 2,025,043 | - | 2,280,261 |
| Mineral rights and interests | - | 100,000 | 16,753 | - | 116,753 |
| Land | 1,493,609 | 914,443 | - | - | 2,408,052 |
| Construction in progress | - | - | 8,951 | - | 8,951 |
| PP&E, cost | $3,708,112 | $1,420,958 | $8,058,441 | $234,174 | $13,421,685 |
| Accumulated depreciation | (1,723,941) | (235,024) | (3,524,130) | (173,545) | (5,656,640) |
| PP&E, net | $1,984,171 | $1,185,934 | $4,534,311 | $60,629 | $7,765,045 |
In May 2024, the Company made the decision to sell a non-core asset of its zeolite segment, which was a personal residence (“BRZ Home”) located near the operations of its wholly owned subsidiary, Bear River Zeolite Company (“BRZ”). In September 2024, the Company sold its BRZ Home and recorded a gain on this sale as follows:
| Proceeds from the sale | $314,125 |
|---|---|
| Net book value of the BRZ Home | 297,873 |
| Gain on sale | $16,252 |
Mineral rights and interests
In August 2024, the Company acquired the ownership rights to ninety-seven mining claims and three mining leases located in the Sudbury District of Ontario, Canada (“Sudbury Agreement”). Payments are to be made by the Company by the following dates for the Company to acquire these claims and leases, of which the Company has made the first payment of $10,000:
| Payment Date | Payment Amount |
|---|---|
| August 2024 | $10,000 |
| November 2024 | 15,000 |
| February 2025 | 35,000 |
| August 2025 | 40,000 |
| August 2026 | 50,000 |
| August 2027 | 50,000 |
| August 2028 | 75,000 |
| Total | $275,000 |
These payments to acquire the mining claims and leases are capitalized when paid in the “Mineral rights and interests” component of “Properties, plants and equipment, net” in the Condensed Consolidated Balance Sheets, which amounted to $10,000 as of September 30, 2024, and will be amortized over the estimated economic life of the mineral resource based on the units-of-production method.
The Sudbury Agreement requires a royalty payment by the Company of 2.5% of the production from the claims (“Net Smelter Royalty”) with a minimum royalty payment beginning on the fifth anniversary of the agreement of $12,000 per year. 1% of the Net Smelter Royalty can be purchased back by the Company at any time for $1 million. Also, the Sudbury Agreement includes a commitment by the Company to spend an aggregate of $250,000 over four years beginning on the agreement date, with various milestones over this four-year period, in exploring and developing these claims. The Sudbury Agreement can be terminated without cause at any time by the Company with thirty days’ notice.
NOTE 7 – LEASES
In September 2024, the Company executed a contract to lease a metals concentration facility located in Phillipsburg, Montana, which was accounted for as an operating lease. The lease has a term of 18 months with fixed cash payments in advance inthe first six months of the lease of $10,000 per month, or $60,000 in total, and fixed cash payments in advance in the last twelve months of the lease of $95,000 per month, or $1.14 million in total, which includes a fixed monthly fee of $45,000 and a minimum milling fee of $50,000 per month. An additional payment of $50 per ton is due each month in the last twelve months of the lease for all milling in excess of 1,000 tons per month. The Company has not included any milling fee payments above the minimum in its lease liability as it is not deemed probable at this time. $10,000 was paid upon signing the lease, which is being accounted for as an initial direct cost ("IDC"). The Company is amortizing the undiscounted fixed lease cost and the IDC on a straight-line basis over the term of the lease. The Company recorded the present value of the fixed lease cost over the lease term as a lease liability and Right of Use ("ROU") asset. The Company used its incremental borrowing rate of 3.49% as of the date of initial possession of the leased asset when determining the present value of future payments of this operating lease as the rate implicit in the lease was not readily determinable. The lease includes provisions for the Company to use the existing mill building and all contents related to its use and to process owned and non-owned ore containing antimony and other critical minerals. The lease does not include any transfer of ownership of the facility at the end of the lease, nor any option to extend the lease or purchase the facility, nor any residual value guarantees. The Company can terminate the lease without cause with thirty days’ notice and must provide the facility to the lessor at the end of the lease in the same condition as it was received.
The lease liability related to this operating lease, which represents the present value of the lease payments, was $787,477 at inception and $782,646 and $nil at September 30, 2024 and December 31, 2023, respectively. The ROU asset, which includes the unamortized portions of the IDC and is adjusted for any accrued or prepaid lease, was $764,035 and $nil at September 30, 2024 and December 31, 2023, respectively. During the three and nine months ended September 30, 2024 and 2023, the Company recorded $33,611 and $nil, respectively, of lease expense related to this lease and IDC in "Cost of Revenues" in the Condensed Consolidated Statements of Operations. IDC paid upon signing this lease was $10,000 and $nil and lease payments were $15,000 and $nil during the three and nine months ended September 30, 2024 and 2023, respectively, which were included in operating cash flows.
The following table summarizes expense and cash payments for operating leases during the periods noted:
| For the three and nine months ended | |||
|---|---|---|---|
| September 30, 2024 · September 30, 2023 | |||
| Operating lease expense | $33,611 | $ | - |
| Cash paid for operating lease liability | $15,000 | $ | - |
| Cash paid for initial direct cost | $10,000 | $ | - |
The following table contains the remaining lease term and discount rate as of the end of the period:
| Remaining lease term - operating lease | 17.5 months |
|---|---|
| Discount rate - operating lease | 3.49% |
The table below is a maturity analysis of the future minimum lease payments as of September 30, 2024.
| Twelve months ending September 30, | |
|---|---|
| 2025 | $757,500 |
| 2026 | 427,500 |
| Total undiscounted future minimum lease payments | 1,185,000 |
| Less: discount on lease liability | (402,354) |
| Total discounted operating lease liability at September 30, 2024 | 782,646 |
| Less: current portion of operating lease liability | (483,211) |
| Noncurrent operating lease liability | $299,435 |
NOTE 8 – LONG-TERM DEBT
Long-term debt at September 30, 2024 and December 31, 2023 was as follows:
| September 30, 2024 · December 31, 2023 | |||
|---|---|---|---|
| Installment contract payable to Komatsu, bearing interest at 3.49%, payable in 36 monthly installments of $11,799 maturing May 2027; collateralized by the Wheel Loader | $360,026 | $ | - |
| Installment contract payable to Caterpillar Financial Services, bearing interest at 6.65%, payable in 24 monthly installments of $7,210 maturing April 28, 2024; collateralized by 2007 Caterpillar 740 articulated truck | - | 28,443 | |
| Total debt | 360,026 | 28,443 | |
| Less current portion of debt | (131,105) | (28,443) | |
| Long term portion of debt | $228,921 | $ | - |
At September 30, 2024, principal payments on debt were due as follows:
| Twelve months ending September 30, | Principal Payment |
|---|---|
| 2025 | $131,105 |
| 2026 | 135,754 |
| 2027 | 93,167 |
| $360,026 |
NOTE 9 – COMMITMENTS AND CONTINGENCIES
The Company follows U.S. GAAP guidance in determining its accruals and disclosures with respect to loss contingencies and evaluates such accruals and contingencies for each reporting period. Accordingly, estimated losses from loss contingencies are accrued by a charge to income when information available prior to the issuance of the financial statements indicates that it is probable that a loss could be incurred, and the amount of the loss can be reasonably estimated. Legal expenses associated with the contingency are expensed as incurred. If a loss contingency is not probable or reasonably estimable, disclosure of the loss contingency is made in the financial statements when it is at least reasonably possible that a material loss could be incurred.
Historically, from time to time, BRZ is assessed fines and penalties by the Mine Safety and Health Administration (“MSHA”). At September 30, 2024 and December 31, 2023, BRZ had no accrued liabilities relating to such assessments. However, during the nine months ended September 30, 2024, BRZ received four significant and substantial citations from MSHA, all of which have been resolved by BRZ.
On a combined basis, BRZ pays royalties ranging from 8% to 13% on the sale of zeolite products. At September 30, 2024 and December 31, 2023, the Company had accrued royalties payable of $105,174 and $153,429, respectively.
NOTE 10 – STOCKHOLDERS’ EQUITY
On January 25, 2023, the holders of 1,692,672 shares of Series D Preferred stock converted the preferred shares and the Company issued 1,692,672 shares of common stock. The Company also paid the holders $787,730 for cumulative dividends payable as declared on November 28, 2022.1,590,672 shares of the 1,692,672 shares of Series D Preferred stock that were converted and $740,261 of the $787,730 of dividends paid related to the estate of John Lawrence, who was the prior President and Chairman of the Company.
On January 26, 2023, in conjunction with its share repurchase plan, the Company returned to treasury and cancelled 418,696 of its common shares which were repurchased prior to December 31, 2022 for $202,980.
Share-based compensation
The Company had no equity awards outstanding during fiscal year 2023. During the nine months ended September 30, 2024, stock option and RSU awards were granted in accordance with our 2023 Equity Incentive Plan, which was approved by the Company’s shareholders. The Company recognized $152,719 and $nil during the three months ended September 30, 2024 and 2023, respectively, and $453,566 and $nil during the nine months ended September 30, 2024 and 2023, respectively, of share-based compensation expense arising from stock option and RSU grants as follows:
| Three Months Ended September 30, · Nine Months Ended September 30, | ||||||
|---|---|---|---|---|---|---|
| 2024 · 2023 · 2024 · 2023 | ||||||
| Share-based compensation expense: | ||||||
| Stock options | $97,655 | $ | - | $161,124 | $ | - |
| RSUs | $55,064 | $ | - | $292,442 | $ | - |
| Total share-based compensation expense | $152,719 | $ | - | $453,566 | $ | - |
Stock options:
Stock options granted have either a 3-year or 10-year contractual term and are subject to either service or performance-based vesting conditions. The following table shows the annual weighted-average assumptions used to value options granted during the nine months ended September 30, 2024:
| Nine Months Ended | |
|---|---|
| Grant-Date Weighted-Average Assumptions | September 30, 2024 |
| Expected term (in years) | 4.5 |
| Risk-free interest rate | 4.3% |
| Expected dividend yield | 0.0% |
| Expected volatility | 136.0% |
| Fair value per share of options granted | $0.18 |
Expected term – The expected term represents the period of time that options are expected to be outstanding. As the Company does not have sufficient historical exercise behavior, it uses the contractual term of the option for the expected term assumption.
Risk-free interest rate – The risk-free interest rate is based on the U.S. Treasury rate in effect at the time of the grant with an equivalent term approximating the expected term of the options.
Expected dividend yield—The Company bases the expected dividend yield assumption on the fact that it has never paid cash dividends and has no present intention to pay cash dividends.
Expected volatility – The expected volatility is based on the historical volatility of our stock price over the expected term of the stock option.
Activity with respect to stock options is summarized as follows:
| Weighted-Average | ||||
|---|---|---|---|---|
| Weighted-Average · Remaining · Aggregate | ||||
| Exercise Price · Contractual · Intrinsic | ||||
| Shares | Per Share | Term (in years) | Value | |
| Options outstanding, December 31, 2023 | - | n/a | n/a | n/a |
| Granted | 4,330,000 | $0.23 | n/a | n/a |
| Exercised | - | n/a | n/a | n/a |
| Forfeited | - | n/a | n/a | n/a |
| Expired | - | n/a | n/a | n/a |
| Options outstanding, September 30, 2024 | 4,330,000 | $0.23 | 4.0 | $2,279,400 |
| Nonvested options, September 30, 2024 | 4,272,500 | $0.23 | 3.9 | $2,254,175 |
| Vested and exercisable options, September 30, 2024 | 57,500 | $0.32 | 9.8 | $25,225 |
At September 30, 2024, total unrecognized share-based compensation expense related to stock options was $634,781, which is expected to be recognized over a weighted-average remaining period of 2.3 years.
Restricted stock units:
Activity with respect to RSUs is summarized as follows:
| Weighted-Average | ||
|---|---|---|
| Grant-Date | ||
| Fair Value | ||
| Shares | Per Share | |
| Nonvested shares at December 31, 2023 | - | n/a |
| Granted | 2,870,000 | $0.23 |
| Vested | (791,667) | $0.22 |
| Forfeited | - | n/a |
| Nonvested shares at September 30, 2024 | 2,078,333 | $0.24 |
At September 30, 2024, total unrecognized share-based compensation expense related to RSUs was $373,108, which is expected to be recognized over a weighted-average remaining period of 1.8 years.
Common stock warrants
No warrants were issued, expired, or exercised during the nine months ended September 30, 2024 and 2023.
The composition of the Company’s warrants outstanding at September 30, 2024 and 2023 was as follows:
| Number of warrants | Exercise Price | Expiration Date | Remaining life (years) |
|---|---|---|---|
| 2,285,715 | $0.46 | 1/27/2026 | 1.33 |
| 804,000 | $0.46 | 1/27/2026 | 1.33 |
| 7,650,000 | $0.85 | 8/3/2026 | 1.84 |
| 1,606,500 | $0.85 | 2/1/2026 | 1.34 |
NOTE 11 – BUSINESS SEGMENTS
The Company is organized and managed with four business segments, which represent our operating units: United States antimony operations, Mexico antimony operations, precious metals recovery and United States zeolite operations. SeeNote 12 for the Mexico discontinued operations that are excluded from business segments.
Total assets by segment at September 30, 2024 and December 31, 2023 were as follows:
| Total Assets, Excluding Discontinued Operations | September 30, 2024 | December 31, 2023 |
|---|---|---|
| Antimony segment: | ||
| United States | $16,514,199 | $14,769,408 |
| Mexico | 1,239,959 | 1,211,319 |
| Subtotal antimony segment | $17,754,158 | $15,980,727 |
| Precious metals segment: | ||
| United States | $142,925 | $92,718 |
| Mexico | - | - |
| Subtotal precious metals segment | $142,925 | $92,718 |
| Zeolite segment | 5,663,794 | 5,474,010 |
| Total assets, excluding discontinued operations | $23,560,877 | $21,547,455 |
Total capital expenditures by segment for the three and nine months ended September 30, 2024 and 2023 were as follows:
| Capital expenditures, Excluding Discontinued Operations · For the three months ended · For the nine months ended | |||||
|---|---|---|---|---|---|
| September 30, 2024 · September 30, 2023 · September 30, 2024 · September 30, 2023 | |||||
| Antimony segment: | |||||
| United States capital expenditures | $10,000 | $ | - | $10,000 | $61,849 |
| Mexico capital expenditures | - | - | - | - | |
| Subtotal antimony segment | $10,000 | $ | - | $10,000 | $61,849 |
| Precious metals segment | - | - | - | - | |
| Zeolite segment | 62,337 | 141,864 | 213,058 | 1,275,549 | |
| Total capital expenditures, excluding discontinued operations | $72,337 | $141,864 | $223,058 | $1,337,398 | |
The zeolite segment’s capital expenditures for the nine months ended September 30, 2024 excludes $402,722 related to a wheel loader purchased with a note payable.
Selected segment operational information excluding discontinued operations for the three and nine months ended September 30, 2024 and 2023 were as follows:
| For the three months ended September 30, 2024 · Antimony USA · Antimony Mexico · Total Antimony · Precious Metals · Zeolite · Total | |||||||
|---|---|---|---|---|---|---|---|
| Total revenues | $1,338,640 | $ | - | $1,338,640 | $399,433 | $682,947 | $2,421,020 |
| Depreciation and amortization | 14,048 | 4,023 | 18,071 | 5,854 | 95,659 | 119,584 | |
| Income (loss) from operations | $(809,755) | $(26,196) | $(835,951) | $393,579 | $(402,671) | $(845,043) | |
| Other income | 161,946 | ||||||
| Income tax expense | - | ||||||
| Loss from continuing operations | $(683,097) | ||||||
| For the three months ended September 30, 2023 · Antimony USA · Antimony Mexico · Total Antimony · Precious Metals · Zeolite · Total | ||||||||
|---|---|---|---|---|---|---|---|---|
| Total revenues | $1,391,733 | $ | - | $1,391,733 | $ | - | $671,825 | $2,063,558 |
| Depreciation and amortization | 10,361 | 4,015 | 14,376 | 5,854 | 73,194 | 93,424 | ||
| Income (loss) from operations | $47,534 | $(25,990) | $21,544 | $(5,854) | $(379,421) | $(363,731) | ||
| Other income | 178,946 | |||||||
| Income tax expense | - | |||||||
| Loss from continuing operations | $(184,785) | |||||||
| For the nine months ended September 30, 2024 · Antimony USA · Antimony Mexico · Total Antimony · Precious Metals · Zeolite · Total | |||||||
|---|---|---|---|---|---|---|---|
| Total revenues | $5,381,803 | $ | - | $5,381,803 | $404,049 | $2,280,338 | $8,066,190 |
| Depreciation and amortization | 42,036 | 12,071 | 54,107 | 17,563 | 268,547 | 340,217 | |
| Income (loss) from operations | $(452,858) | $(78,589) | $(531,447) | $386,486 | $(982,432) | $(1,127,393) | |
| Other income | $474,693 | ||||||
| Income tax expense | - | ||||||
| Loss from continuing operations | $(652,700) | ||||||
| For the nine months ended September 30, 2023 · Antimony USA · Antimony Mexico · Total Antimony · Precious Metals · Zeolite · Total | |||||||
|---|---|---|---|---|---|---|---|
| Total revenues | $4,356,077 | $ | - | $4,356,077 | $242,433 | $1,941,009 | $6,539,519 |
| Depreciation and amortization | 29,002 | 12,054 | 41,056 | 17,563 | 189,263 | 247,882 | |
| Income (loss) from operations | $(207,907) | $(77,979) | $(285,886) | $224,870 | $(420,174) | $(481,190) | |
| Other income | 566,754 | ||||||
| Income tax expense | - | ||||||
| Income from continuing operations | $85,564 | ||||||
NOTE 12 – DISCONTINUED OPERATIONS AND ASSETS HELD FOR SALE
As described inNote 1, on March 11, 2024, the Company shut down the operations of USAMSA, which was part of the antimony segment, and announced its intent to sell its USAMSA subsidiary. The accounting requirements for reporting USAMSA as a discontinued operation were met in the first quarter of 2024. Accordingly, our Condensed Consolidated Balance Sheets, Condensed Consolidated Statements of Operations, and Condensed Consolidated Statements of Cash Flows report discontinued operations separate from continuing operations for all periods presented. Our Condensed Consolidated Statements of Equity combine the results of continuing and discontinued operations. In addition, the Notes to Condensed Consolidated Financial Statements exclude discontinued operation for all periods presented.
The key components of the income (loss) from discontinued operations for the three and nine months ended September 30, 2024 and 2023 were as follows:
| For the three months ended | For the nine months ended | |||
|---|---|---|---|---|
| September 30, 2024 | September 30, 2023 | September 30, 2024 | September 30, 2023 | |
| REVENUES | $151,158 | $249,933 | $1,241,032 | $488,389 |
| COST OF REVENUES | 153,097 | 1,569,413 | 1,134,808 | 2,828,794 |
| GROSS PROFIT (LOSS) | (1,939) | (1,319,480) | 106,224 | (2,340,405) |
| OPERATING EXPENSES: | ||||
| General and administrative | 22,072 | 11,032 | 92,472 | 49,301 |
| Professional fees | 18,563 | 63,681 | 72,893 | 164,625 |
| Other operating expenses | 3,404 | 66,637 | 118,933 | 310,985 |
| TOTAL OPERATING EXPENSES | 44,039 | 141,350 | 284,298 | 524,911 |
| LOSS FROM OPERATIONS | (45,978) | (1,460,830) | (178,074) | (2,865,316) |
| OTHER INCOME (EXPENSE): | ||||
| Other miscellaneous income (expense) | 1,566 | 1,087 | (16,711) | (8,225) |
| TOTAL OTHER INCOME (EXPENSE) | 1,566 | 1,087 | (16,711) | (8,225) |
| LOSS FROM DISCONTINUED OPERATIONS, BEFORE TAX | (44,412) | (1,459,743) | (194,785) | (2,873,541) |
| Income tax expense | - | - | - | - |
| LOSS FROM DISCONTINUED OPERATIONS, NET OF TAX | $(44,412) | $(1,459,743) | $(194,785) | $(2,873,541) |
Depreciation and amortization expense of USAMSA totaled $nil for the three and nine months ended September 30, 2024, and $155,538 and $466,421 for the three and nine months ended September 30, 2023, respectively.
Capital expenditures of USAMSA were $nil for the three and nine months ended September 30, 2024, and $30,000 and $182,322 for the three and nine months ended September 30, 2023, respectively.
The carrying amounts of major classes of assets and liabilities of USAMSA included in assets and liabilities of discontinued operations were as follows:
| September 30, 2024 · December 31, 2023 | |||
|---|---|---|---|
| ASSETS | |||
| CURRENT ASSETS | |||
| Accounts receivable | $40,193 | $ | - |
| Inventories, net | 31,457 | 366,955 | |
| Prepaid expenses and other current assets | 2,910 | - | |
| Total current assets, discontinued operations | 74,560 | 366,955 | |
| Properties, plants and equipment, net | 5,689,446 | 5,689,446 | |
| IVA receivable and other assets, net | 428,164 | 491,139 | |
| Total assets, discontinued operations | $6,192,170 | $6,547,540 | |
| LIABILITIES | |||
| CURRENT LIABILITIES | |||
| Accounts payable | 133,780 | 126,788 | |
| Accrued liabilities | 15,053 | 24,500 | |
| Total current liabilities, discontinued operations | 148,833 | 151,288 | |
| Asset retirement obligations | 536,466 | 536,466 | |
| Total liabilities, discontinued operations | $685,299 | $687,754 | |
Mexico Tax Assessment
In 2015, the Mexican tax authority (“SAT”) initiated an audit of the USAMSA’s 2013 income tax return. In October 2016, as a result of its audit, SAT assessed the Company $13.8 million pesos, which was approximately $666,400 in U.S. Dollars (“USD”) as of December 31, 2016. SAT’s assessment was based on the disallowance of specific costs that the Company deducted on the 2013 USAMSA income tax return. The assessment was settled in 2018 with no assessment due from the Company.
In 2019, the Company was notified that SAT re-opened its assessment of USAMSA’s 2013 income tax return and, in November 2019, SAT assessed the Company $16.3 million pesos, which was approximately $865,000 USD as of December 31, 2019. Management reviewed the 2019 assessment notice from SAT and, similar to the earlier assessment, believed the findings have no merit. An appeal was filed by the Company in November 2019 suspending SAT from taking immediate action regarding the assessment. In August 2020, the Company filed a lawsuit against SAT for resolution of the process and, in December 2020, filed closing arguments. In 2022, the Mexican court ruled against the Company in the above matter, which was subsequently appealed by the Company.
As of December 31, 2023, the updated SAT assessment was approximately $22.4 million pesos, or approximately $1,320,000 USD, which includes $352,000 of unpaid income taxes and $968,000 of interest and penalties. Management, along with its legal counsel, assessed the possible outcomes for this tax audit and believed, based on discussions with its attorneys located in Mexico, that the most likely outcome would be that the Company would be successful in its appeal resulting in no tax due. Management determined that no amount should be accrued at December 31, 2023 relating to this potential tax liability.
In March 2024, Mexico’s appellate court ruled in favor of the Company with no assessment due related to this audit of USAMSA’s 2013 income tax return by SAT and instructed the lower court to issue a new ruling. In May 2024, Mexico’s lower court issued a final ruling on this matter in favor of the Company but left open the possibility for the SAT to re-open their audit. Subsequent to this judgment, the Company requested a final ruling on whether SAT can re-open this matter, on which the appellate court has not ruled. These rulings support the Company’s position on this tax matter and have had no impact on the Company’s financial statements.
Mexico Value Added Tax
USAMSA records a receivable for the Value Added Tax (“VAT” or “IVA”) it pays on certain goods and services representing amounts to be reimbursed from the Mexican government. This receivable balance of $973,414 and $1,122,628 at September 30, 2024 and December 31, 2023, respectively, is recorded in “IVA receivable and other assets, net” in USAMSA’s assets held for sale in discontinued operations net of a reserve of $601,295 and $687,534 at September 30, 2024 and December 31, 2023, respectively.
Note 13 - SUBSEQUENT EVENTS
On November 12, 2024, the Company entered into a Sales Agreement (“Sales Agreement’) with A.G.P./Alliance Global Partners (“A.G.P.”) to sell shares of the Company’s common stock, with aggregate gross proceeds of up to $25,000,000, from time to time, through an “at the market offering” program under which A.G.P. will act as sales agent.
Under the Sales Agreement, the Company will set the parameters for the sale of shares, including the number of shares to be issued, the time period during which sales are requested to be made, limitations on the number of shares that may be sold in any one trading day and any minimum price below which sales may not be made. The Sales Agreement provides that A.G.P. will be entitled tocompensation for its services in an amount equal to up to 3.0% of the gross proceeds from the sale of shares sold under the Sales Agreement. The Company has no obligation to sell any shares under the Sales Agreement and may suspend solicitation and offers under the Sales Agreement. The shares will be issued pursuant to the Company’s shelf registration statement on Form S-3 and the Prospectus Supplement to be filed on November 12, 2024 with the U.S. Securities and Exchange Commission in connection with the offer and sale of the shares pursuant to the Sales Agreement.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.